Bind Biosciences

COMPANY

Company Management Board of Directors Scientific Advisors Clinical Advisors History Contact

Clinical Advisors

Neil Bander, M.D.
Chaus Professor of Urologic Oncology, Weill Medical College and Cornell University

Peter D. Eisenberg, M.D.
Medical Oncologist, California Cancer Care

Philip Kantoff, M.D.
Chief Clinical Research Officer, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School

Mark G. Kris, M.D.
Chief, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan-Kettering Cancer Center

Maurie Markman, M.D.
Vice President for Clinical Research, The University of Texas M. D. Anderson Cancer Center

Joyce O'Shaugnessy, M.D.
Co-chair of Breast Cancer Research, Baylor Charles A Sammons Cancer Center, Texax Oncology, US Oncology 

Christopher Sweeney, M.B.B.S.
Medical Oncologist, Dana-Farber Cancer Institute

Anthony W. Tolcher, M.D.
Director of Clinical Research, South Texas Accelerated Research Therapeutics (START)

Daniel D. Von Hoff, M.D.
Physician-in-Chief, Translational Genomics Research Institute (TGen)
Clinical Professor of Medicine, University of Arizona